Prellis Biologics Announces Collaboration and License Agreement with Bristol Myers Squibb

SAN FRANCISCO--(BUSINESS WIRE)-- #BMS--Prellis Biologics announced a multi-target drug discovery collaboration and license agreement with Bristol Myers Squibb.

Click to view original post